> ## Content Index
> Fetch the complete content index at: https://adjacent.media/llms.txt
> Use this file to discover other available public pages before exploring further.

# RFK Jr. opens door to peptide telehealth boom
- URL: https://adjacent.media/signals/rfk-jr-opens-door-to-peptide-telehealth-boom/
- Published: 2026-04-23T16:01:43.000Z
- Updated: 2026-04-23T16:01:43.000Z
- Description: Kennedy’s regulatory push to relax peptide restrictions creates a direct commercial opportunity for telehealth platforms like GoodRx and Ro, which have already built infrastructure to distribute compounded medications at scale.
- Author: Jonathan Greene
- Tags: #signal, theme-consumer, consumer behavior, health tech

Source: [Axios](https://www.axios.com/2026/04/23/rfk-peptide-push-glp1-wellness-boom?ref=adjacent.media)

Kennedy's regulatory push to relax peptide restrictions creates a direct commercial opportunity for telehealth platforms like GoodRx and Ro, which have already built infrastructure to distribute compounded medications at scale. The move mirrors how ketamine clinics and GLP-1 distribution networks captured consumer spend by operating in regulatory gray zones—except peptides, used for muscle building and anti-aging, appeal to a broader wellness market than psychiatric or weight-loss drugs. If peptides move from black-market fitness supplements to FDA-adjacent telehealth products, the winner is not the wellness industry broadly but the companies with existing prescriber networks and patient data that can convert curiosity into recurring revenue.